E-viri
PDF
Recenzirano
Odprti dostop
-
Kochanek, Matthias; Schalk, E.; von Bergwelt-Baildon, M.; Beutel, G.; Buchheidt, D.; Hentrich, M.; Henze, L.; Kiehl, M.; Liebregts, T.; von Lilienfeld-Toal, M.; Classen, A.; Mellinghoff, S.; Penack, O.; Piepel, C.; Böll, B.
Annals of hematology, 05/2019, Letnik: 98, Številka: 5Journal Article
Sepsis and septic shock are major causes of mortality during chemotherapy-induced neutropenia for malignancies requiring urgent treatment. Thus, awareness of the presenting characteristics and prompt management is most important. Improved management of sepsis during neutropenia may reduce the mortality of cancer therapies. However, optimal management may differ between neutropenic and non-neutropenic patients. The aim of the current guideline is to give evidence-based recommendations for hematologists, oncologists, and intensive care physicians on how to manage adult patients with neutropenia and sepsis.
